Høgdall CK, Høgdall EV, Hørding U, Toftager-Larsen K, Arends J, Nørgaard-Pedersen B, et al. Use of Tetranectin, CA-125 and Casa to Predict Residual Tumor and Survival at Second- and Third-Look Operations for Ovarian Cancer. AO [Internet]. 1996 Jan. 1 [cited 2024 Nov. 12];35(1):63-9. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/27737